Sponsor

University of Hull

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name University of Hull appears in 19 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials19
Recruiting shown1
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

19 shown
Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS)NCT05646199 · lead sponsor · 2025-03-01
UNKNOWN
Exercise for Ameliorating Chemotherapy CardiotoxicityNCT06595316 · lead sponsor · 2024-10-15
UNKNOWN
FreeStyle Libre Monitoring in T2DMNCT05597293 · lead sponsor · 2023-02-27
COMPLETED
Feasibility Trial of a Personalised Nutrition and Activity Programme for People With Lung Cancer Over 65 YearsNCT05404022 · lead sponsor · 2022-06-20
COMPLETED
Comprehensive Geriatric Assessment in Elderly Non-Small Cell Lung Cancer PatientsNCT05230888 · lead sponsor · 2022-02-09
WITHDRAWN
Feasibility and Acceptability of an Web-based Physical Activity Program, for Those Diagnosed With Lung Cancer.NCT05121259 · lead sponsor · 2021-11-22
COMPLETED
A Study to Identify Biomarkers of Hypoglycaemia in Patients With Type 2 DiabetesNCT03102801 · lead sponsor · 2017-03-01
COMPLETED
Home-based Resistance Training for Adults With Severe ObesityNCT03900962 · lead sponsor · 2017-01-09
COMPLETED
Environmental Effects Type 1 Diabetes MellitusNCT03102476 · lead sponsor · 2016-06-01
COMPLETED
The Effects of Hypoglycaemia in People With Type 2 DiabetesNCT02205996 · lead sponsor · 2011-11-01
COMPLETED
Effects of the Sugar Sucrose on Bodyweight and Energy Intake Over 28 Days in Obese WomenNCT01799096 · lead sponsor · 2006-09-01
COMPLETED
Preparatory Work for a Trial of Adjuncts to Diuretic Treatment in Patients Hospitalised With Heart Failure: Addressing Uncertainties and Building ConsensusNCT07281040 · collaborator · 2025-07-02
RECRUITING
Prehabilitation and RecOVERy From Surgery for Breast Cancer StudyNCT05901142 · collaborator · 2023-06-16
UNKNOWN
Evaluating the Role of Ultrasound in Prostate CancerNCT05326282 · collaborator · 2021-12-06
COMPLETED
Extracorporeal Shockwave Therapy for Diabetic Foot WoundsNCT04042285 · collaborator · 2019-02-01
COMPLETED
HbA1c Variability in Type II DiabetesNCT02879409 · collaborator · 2016-11-01
ACTIVE_NOT_RECRUITING
Environmental Chemicals That Accumulate in FatNCT03726567 · collaborator · 2012-10-12
COMPLETED
Effects of Combining Cocoa and Soy in Type 2 DiabetesNCT01754662 · collaborator · 2011-10-01
COMPLETED
Studies Investigating Co-morbidities Aggravating Heart FailureNCT01872299 · collaborator · 2010-03-01
COMPLETED

Drugs studied in this sponsor's trials

8 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing University of Hull as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
insulin, regular, human2
metformin2
dapagliflozin1
gliclazide1
Humalog1
liraglutide1
pioglitazone1
sitagliptin1

Sponsor roles

lead sponsor11
collaborator8
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.